Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function

Journal of Internal Medicine

Volumn 255, Issue 3, 2004, Pages 332-343

  Muller S ^a   Ronfani, L ^a   Bianchi, M E ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Chromatin; Development; HMGB; Inflammation; Metastasis

Indexed keywords

APOPTOSIS INHIBITOR; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN;

CANCER INVASION; CELL DEATH; CELL LEVEL; CELLULAR DISTRIBUTION; CHROMATIN; CONFERENCE PAPER; CYTOKINE RELEASE; DRUG DESIGN; EXTRACELLULAR SPACE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TISSUE LEVEL; TUMOR;

APOPTOSIS; CELL COMMUNICATION; CELL NUCLEUS; CYTOKINES; EXTRACELLULAR SPACE; GENE EXPRESSION; HMGB1 PROTEIN; HUMANS; NEOPLASMS; NERVOUS SYSTEM; TRANSCRIPTION, GENETIC;

EID: 1542345501     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2003.01296.x     Document Type: Conference Paper

References (69)

1. Goodwin GH, Sanders C, Johns EW. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 1973; 38: 14-9.
2. Thomas JO, Travers AA. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem Sci 2001; 26: 167-74.
3. Janke C, Martin D, Giraud-Panis MJ, Decoville M, Locker D. Drosophila DSP1 and rat HMGB1 have equivalent DNA binding properties and share a similar secondary fold. J Biochem (Tokyo) 2003; 133: 533-9.
4. Agresti A, Bianchi ME. HMGB proteins and gene expression. Curr Op Genet Develop 2003; 13: 170-8.
5. Zayed H, Izsvak Z, Khare D, Heinemann U, Ivics Z. The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. Nucleic Acids Res 2003; 31: 2313-22.
6. Bonaldi T, Längst G, Strohner R, Becker PB, Bianchi ME. The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding. EMBO J 2002; 21: 6865-73.
7. Calogero S, Grassi F, Aguzzi A et al. The lack of chromosomal protein HMG1 does not disrupt cell growth, but causes lethal hypoglycaemia in newborn mice. Nature Genet 1999; 22: 276-80.
8. Brezniceanu ML, Volp K, Bosser S et al. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J 2003; 17: 1295-7.
9. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-5.
10. Degryse B, Bonaldi T, Scaffidi P et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001; 152: 1197-2006.
11. Palumbo R, Sampaolesi M, De Marchis et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 2004; in press.
12. Wang H, Bloom O, Zhang M et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-51.
13. Andersson U, Wang H, Palmblad K et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192: 565-70.
14. Park JS, Arcaroli J, Yum HK et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003; 284: C870-9.
15. Passalacqua M, Zicca A, Sparatore B, Patrone M, Melloni E, Pontremoli S. Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation. FEBS Lett 1997; 400: 275-9.
16. Passalacqua M, Patrone M, Picotti GB et al. Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience 1998; 82: 1021-8.
17. Fages C, Nolo R, Huttunen HJ, Eskelinen E, Rauvala H. Regulation of cell migration by amphoterin. J Cell Sci 2000; 113: 611-20.
18. Taguchi A, Blood DC, del Toro G et al. Blockage of RAGE-amphoterin signalling suppresses tumour growth and metastasis. Nature 2000; 405: 354-60.
19. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, Rauvala H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 2002; 62: 4805-11.
20. Mosevitsky MI, Novitskaya VA, Iogannsen MG, Zabezhinsky MA. Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions. Eur J Biochem 1989; 185: 303-10.
21. Seyedin SM, Pehrson JR, Cole RD. Loss of chromosomal high mobility group proteins HMG1 and HMG2 when mouse neuroblastoma and Friend erythroleukemia cells become committed to differentiation. Proc Natl Acad Sci USA 1981; 78: 5988-92.
22. Begum N, Pash JM, Bhorjee JS. Expression and synthesis of high mobility group chromosomal proteins in different rat skeletal cell lines during myogenesis. J Biol Chem 1990; 265: 11936-41.
23. 0 histone in various blood cells. Cell Biochem Funct 1995; 13: 125-33.
24. Prasad S, Thakur MK. Distribution of high mobility group proteins in different tissues of rats during aging. Biochem Int 1990; 20: 687-95.
25. Daston MM, Ratner N. Expression of p30, a protein with adhesive properties, in Schwann cells and neurons of the developing and regenerating peripheral nerve. J Cell Biol 1991; 112: 1229-39.
26. Chou DK, Evans JE, Jungalwala FB. Identity of nuclear high-mobility-group protein, HMG-1, and sulfoglucuronyl carbohydrate-binding protein, SBP-1, in brain. J Neurochem 2001; 77: 120-31.
27. Merenmies J, Pihlaskari R, Laitinen J, Wartiovaara J, Rauvala H. 30-kD heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 1991; 266: 16722-9.
28. Guazzi S, Strangio A, Franzi AT, Bianchi ME. HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expr Patterns 2003; 3: 29-33.
29. Kobori N, Clifton GL, Dash P. Altered expression of novel genes in the cerebral cortex following experimental brain injury. Brain Res Mol Brain Res 2002; 104: 148-58.
30. Zhao Z, Nair SM, Chou DK, Tobet SA, Jungalwala FB. Expression and role of sulfoglucoronyl (HNK-1) carbohydrate and its binding protein SBP-1 in developing rat cerebral cortex. J Neurosci Res 2000; 62: 186-205.
31. Zhao Z, Chou DKH, Nair SM, Tobet S, Jungalwala FB. Expression of sulfoglucuronyl (HNK-1) carbohydrate and its binding protein (SBP-1) in developing rat cerebellum. Dev Brain Res 2000; 120: 165-80.
32. Takata K, Kitamura Y, Kakimura J et al. Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. Biochem Biophys Res Commun 2003; 301: 699-703.
33. Daston MM, Ratner N. Amphoterin (P30, HMG-1) and RIP are early markers of oligodendrocytes in the developing rat spinal cord. J Neurocytol 1994; 23: 323-32.
34. Kawahara N, Tanaka T, Yokomizo A et al. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin. Cancer Res 1996; 56: 5330-3.
35. Xiang YY, Wang DY, Tanaka M et al. Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa. Int J Cancer 1997; 74: 1-6.
36. Flohr AM, Rogalla P, Meiboom M et al. Variation of HMGB1 expression in breast cancer. Anticancer Res 2001; 21: 3881-5.
37. Poser I, Golob M, Buettner R, Bosserhoff AK. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol 2003; 23: 2991-8.
38. Choi YR, Kim H, Kang HJ et al. Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. Cancer Res 2003; 63: 2188-93.
39. Kuniyasu H, Oue N, Wakikawa A et al. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 2002; 196: 163-70.
40. Kuniyasu H, Chihara Y, Kondo H, Ohmori H, Ukai R. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer. Oncol Rep 2003; 10: 1863-8.
41. Kuniyasu H, Chihara Y, Takahashi T. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. Oncol Rep 2003; 10: 445-8.
42. Nestl A, von Stein OD, Zatloukal K et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 2001; 61: 1569-77.
43. Ronfani L, Ferraguti M, Croci L et al. Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2. Development 2001; 128: 1265-73.
44. Vaccari T, Beltrame M, Ferrari S, Bianchi ME. Hmg4, a new member of the Hmg1/2 gene family. Genomics 1998; 49: 247-52.
45. Nemeth MJ, Curtis DJ, Kirby MR et al. Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation. Blood 2003; 102: 1298-306.
46. Bonaldi T, Talamo F, Scaffidi P et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003; 22: 5551-60.
47. Gardella S, Andrei C, Ferrera D et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002; 3: 995-1001.
48. Blott EJ, Griffiths GM. Secretory lysosomes. Nat Rev Mol Cell Biol 2002; 3: 122-31.
49. Andrei C, Dazzi C, Lotti L, Torrisi MR, Chimini G, Rubartelli A. The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 1999; 10: 1463-75.
50. Bustin M, Neihart NK. Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell 1979; 16: 181-9.
51. Ferrari S, Ronfani L, Calogero S, Bianchi ME. The mouse gene coding for high mobility group 1 protein (HMG1). J Biol Chem 1994; 269: 28803-8.
52. Ferrari S, Finelli P, Rocchi M, Bianchi ME. The active gene that encodes high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. Genomics 1996; 35: 367-71.
53. Spada F, Brunet A, Mercier Y, Renard J-P, Bianchi ME, Thompson EM. High mobility group 1 (HMG1) protein in mouse preimplantation embryos. Mech Develop 1998; 76: 57-66.
54. Lum HK, Lee K-LD. The human HMGB1 promoter is modulated by a silencer and an enhancer-containing intron. Biochim Biophys Acta 2001; 1520: 79-84.
55. Borrmann L, Kim I, Schultheiss D, Rogalla P, Bullerdiek J. Regulation of the expression of HMG1, a co-activator of the estrogen receptor. Anticancer Res 2001; 21: 301-5.
56. Chau KY, Lam HYP, Lee KLD. Estrogen treatment induces elevated expression of HMG1 in MCF-7 cells. Exp Cell Res 1998; 241: 269-72.
57. He Q, Liang CH, Lippard SJ. Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proc Natl Acad Sci USA 2000; 97: 5768-72.
58. Uramoto H, Izumi H, Nagatani G et al. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression. Biochem J 2003; 371: 301-10.
59. Nagatani G, Nomoto M, Takano H et al. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells. Cancer Res 2001; 61: 1592-7.
60. Sass G, Heinlein S, Agli A, Bang R, Schumann J, Tiegs G. Cytokine expression in three mouse models of experimental hepatitis. Cytokine 2002; 19: 115-20.
61. Fang WH, Yao YM, Shi ZG et al. The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury. Shock 2002; 17: 329-33.
62. Wang SB, Yao YM, Dong N, Yu Y, Tao GC. Role of Janus kinase/signal transducer and activator of transcription pathway in mediating mRNA expression of high mobility group box 1 protein in the liver in septic rats [Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2003; 15: 147-9.
63. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999; 19: 5237-46.
64. Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Reviews 1999; 99: 2467-98.
65. Pasheva EA, Ugrinova I, Spassovska NC, Pashev IG. The binding affinity of HMG1 protein to DNA modified by cisplatin and its analogs correlates with their antitumor activity. Int J Biochem Cell Biol 2002; 34: 87-92.
66. Wei M, Burenkova O, Lippard SJ. Cisplatin sensitivity in Hmgb1-/- and Hmgbl+/+ mouse cells. J Biol Chem 2002; 278: 1769-73.
67. Krynetski EY, Krynetskaia NF, Bianchl ME, Evans WE. A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues. Cancer Res 2003; 63: 100-6.
68. Taniguchi N, Kawahara K, Yone K et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003; 48: 971-81.
69. Kokkola R, Li J, Sundberg E et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 2003; 48: 2052-8.